Strong growth masks margin compression; commodity pass-through pending

Delivered INR 344.7 crores, YoY +22.6%. Claim accurate.

Delivered NPM 7.7%, OPM 10.9%. Gross margin 34.2% (down from inflation). EBITDA growth not independently verifiable but margin trajectory below 12%-13% target.

QoQ revenue +11.4% but PAT -2.4%, confirming margin compression. MD's attribution to inflation is plausible but actual NPM 7.7% is materially below target.

H1 = INR 654 crores (40.8% of target). Q1 ~INR 309 Cr, Q2 INR 344.7 Cr. At 22%+ YoY growth, FY27 run-rate supports ~INR 900-950 crores if growth sustains. Target of 2K requires acceleration.

Prior calls aspired 100-200 bps EBITDA improvement. Q2 shows OPM 10.9% vs 12%-13% target. MD now hedges as 'early days Q3', implying slower recovery than expected. Commodity headwinds more severe than guided.

Prior guidance: outperform IIP/GDP growth. Delivered 22.6% YoY revenue growth, well ahead of macro. Infrastructure, power, shipbuilding benefiting. Export acceleration (15%-20%) adds growth vector.

FY27 capex INR 30-35 Cr (vs prior INR 30-40 Cr). Maintained. Next 2 years INR 60-70 Cr (normalized level). No new CapEx intensity signal, confirming prior investment plan.

Prior call: Flares/Process Equipment restructured. Q2 confirmed 'nothing major' in flares, no losses. Successfully pruned unprofitable division.

80% of dip is inflation in steel, freight, raw materials. 20% is our growth strategy accepting lower margins. Target is 12%-13% EBITDA level. Confident on recovery.

Mid-teens volume growth. Mix includes steel (primary), electronics, PCBs. All have seen cost inflation. We manage the supply chain dynamically.

WelDoS is a technical add-on giving welder data for efficiency tracking. Automation has strategic value. We are exploring acquisitions but ecosystem is tiny, so we are careful.

75%-80% is order backlog. 15%-20% is steel cost hedging. Will stabilize. It's a mix of demand and macro availability concerns.

Fairly on track. Last 6-9 months show opportunities. Capex will be ₹30-35 crore FY27, then ₹60-70 for next 2 years. No major debt need; balance sheet is strong.

Steel up 7%-8% Q2 vs Q1. I can't comment on when it will soften. We are taking calibrated price hikes. Pass-through is only way to recover margins.

I can't get into excess detail on steel %. Varies by segment (Tier 1, 2, 3 customers). Pass-through in Q3-Q4 is the path to 12%-13% margin.

We are working to deepen top-50, top-100 customers. Fontech brings M&R capability and margin upside. Hiring underway for integration.

Most borrowing is LCs, BGs, and strategic stock for 20% growth target. Will normalize. Capex ₹30-35 FY27, then ₹60-70 for 2 years.

Yes, 20%+ H1 growth shows progress. Exports are 15%-20% with presence in US, Africa, parts of Europe, now entering third Europe market. Middle East is 80%-85% of current exports.

MD states 'fairly on track' based on 20%+ H1 growth and market opportunities. H1 is ₹654 Cr (need ₹1,346 in H2 at similar growth). Achievable but unverified.

Delivered 22.6% YoY. Growth drivers (infrastructure, power, shipbuilding, defense, exports) remain in place for H2.

MD states 'it has to be between 12%-13%' and 'our job is to get it there'. Currently at 11.2% H1, 10.9% OPM Q2. Recovery via price pass-through in Q3-Q4.

Price hikes 'being taken' but timing vague. Commodity volatility global. MD hedges as 'early days Q3'. No specific month or magnitude given.

Within prior ₹30-40 Cr range. Supports consumables, automation, capacity expansion.

Step-up from FY27 normal run-rate, then stabilize. Post capex push for automation, no major debt need expected.

Steel +7%-8% Q2 vs Q1; freight, PCBs, electronics all up. 80% of Q2 margin dip attributed to inflation. MD states price hikes taken but timing of full pass-through to bottom line is 'early days Q3'.

Short-term borrowing jumped from negligible (FY26) to ₹28 Cr. MD attributes 75%-80% to order backlog (positive), 15%-20% to steel cost hedging (volatile). If steel stabilizes, inventory could overshoot.

MD states margin recovery is the 'only way' and hedges as 'early days Q3'. Sequential PAT decline (-2.4% QoQ) despite revenue growth (+11.4% QoQ) shows pass-through not yet visible. No timeline given for target 12%-13% EBITDA achievement.

MD states automation ecosystem is 'very tiny' and the company is 'exploring options' for robotics/automation M&A. Fontech merger is early-stage. No quantified pipeline or timeline. Risk of overpaying or slower integration.

MD notes Ador is 'not as aggressive' as it could be with large direct customers; distribution network strong but wallet share limited. Risk if major infrastructure capex cycle slows or a key customer shifts.